Current Vascular Pharmacology
Title: An Introductory Message from the Editor-in-Chief
Volume: 1 Issue: 1
Author(s): D. P. Mikhailidis
Affiliation:
Export Options
About this article
Cite this article as:
P. Mikhailidis D., An Introductory Message from the Editor-in-Chief, Current Vascular Pharmacology 2003; 1 (1) . https://dx.doi.org/10.2174/1570161033386853
DOI https://dx.doi.org/10.2174/1570161033386853 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aqueous Extract of Argania spinosa L. Fruits Ameliorates Diabetes in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Transcription Factor Pitx3 in Dopamine Neuron Development and Parkinsons Disease
Current Topics in Medicinal Chemistry Statins in Aortic Stenosis
Current Pharmaceutical Design Mobile Phone Based Health Care Technology
Recent Patents on Biomedical Engineering (Discontinued) Pharmacogenomics of Essential Hypertension: Are We Going the Right Way?
Cardiovascular & Hematological Agents in Medicinal Chemistry Statins in the Prevention of Cardiovascular Events in Patients with Renal Failure
Cardiovascular & Hematological Disorders-Drug Targets Pre- and Post-conditioning in Cardiovascular Surgery
Current Vascular Pharmacology Safety of New Oral Anticoagulants for Patients with Chronic Kidney Disease
Current Pharmaceutical Design Cell Immunity in Coronary Artery Disease (CAD)
Current Immunology Reviews (Discontinued) Simultaneous Determination of Simvastatin with Caffeine in Bulk Drug, Formulation and their Monitoring in Mice Plasma Through HPLC-PDA Technique
Current Analytical Chemistry Clinical Significance of the Sympathetic Nervous System in the Development and Progression of Pulmonary Arterial Hypertension
Current Neurovascular Research Molecular Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Hemodialysis Patients
Current Signal Transduction Therapy Effects of Liver Diseases on Drug-metabolizing Enzymes: Implications for Drug Fate Alterations and Nano-therapeutic Openings
Current Medicinal Chemistry Anderson-Fabry Disease: A Multiorgan Disease
Current Pharmaceutical Design Ion Channels as Important Targets for Antiepileptic Drug Design
Current Drug Targets Editorial (Thematic Issue: Anderson Fabry Disease: A Multiorgan Metabolic Disease Susceptible of Treatment)
Current Pharmaceutical Design Hypolipidemic, Antioxidant and Cardioprotective Effects of the Aqueous Extract from <i>Scorzanera Undulata</i> Tubers in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Lessons from the REACH Registry in Europe
Current Vascular Pharmacology Longitudinal Functional MRI of Motor and Cognitive Recovery Following Stroke: A Review
Current Medical Imaging Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
Recent Patents on CNS Drug Discovery (Discontinued)